Literature DB >> 3088106

Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.

C D Rothermel, B Y Rubin, E A Jaffe, H W Murray.   

Abstract

We have demonstrated previously that Chlamydia psittaci grows well in human monocyte-derived macrophages, but to a limited extent in lymphokine-or interferon-gamma (IFN-gamma)-activated macrophages. In this investigation, freshly explanted human monocytes inhibited chlamydial inclusion formation by 85% as compared to macrophages, and the level of inhibition was similar to that exhibited by lymphokine-activated macrophages (79%). To determine whether the oxygen-dependent antimicrobial mechanisms of the mononuclear phagocyte were involved in the inhibition, cells were infected with C. psittaci in the presence of agents that either inhibit the respiratory burst (glucose deprivation) or diminish the effect of H2O2 (catalase). These treatments had no effect on the capacity of monocytes and lymphokine-activated macrophages to restrict chlamydial growth. In addition, monocytes and activated macrophages from an individual with chronic granulomatous disease suppressed chlamydial growth as effectively as normal cells. Oxidatively deficient HeLa and endothelial cells, once stimulated by lymphokine, also displayed normal levels of antichlamydial activity. The induction of this apparently oxygen-independent antichlamydial effect by lymphokine was completely neutralized by a monoclonal anti-IFN-gamma antibody, and could be achieved by treatment with recombinant (r)IFN-gamma alone. These results indicate that the primary antimicrobial mechanism of the human monocyte against C. psittaci is oxygen-independent, and that this response can be effectively stimulated in the macrophage by lymphokine (IFN-gamma).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088106

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 4.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

5.  Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.

Authors:  J T Summersgill; N N Sahney; C A Gaydos; T C Quinn; J A Ramirez
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

6.  Fungicidal mechanisms of activated macrophages: evidence for nonoxidative mechanisms for killing of Blastomyces dermatitidis.

Authors:  E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron.

Authors:  H W Murray; A M Granger; R F Teitelbaum
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 8.  Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 9.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12

10.  Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.

Authors:  S L Newman; L Gootee; C Bucher; W E Bullock
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.